People with diabetes who have had COVID-19 tend to recover more slowly, experience more long COVID complications, have a ...

Using screens during the first 1001 days of life can lead to developmental concerns for the next generation, researchers warn.

Researchers have created a powerful new cellular model to study rare tumors that are resistant to immunotherapies.

A new survey commissioned by The Ohio State University Wexner Medical Center finds young adults are missing out on the health ...

Older adults discharged from hospital with a new prescription for a sedative, especially a benzodiazepine or antipsychotic, are at increased risk of falls and other negative consequences, according to ...

In this interview, AZoLife Sciences speaks with Boyd Butler, a microscopy and high-content screening expert at Molecular ...

A revolutionary scanning technique has revealed that lithium MRI is a powerful tool for studying how the drug interacts with ...

Discover how automation, AI, and organoid technologies are improving drug discovery through scalable workflows.

Fasting blood tests measuring GLP-1 and GIP levels may predict obesity treatment response to semaglutide and tirzepatide, ...

Obesity trends show significant disparities among demographics, stressing the importance of targeted prevention to address ...

Canada recently approved lecanemab to treat early Alzheimer disease, but the clinical benefits are modest, it carries a risk of serious adverse effects, and treatment is complex.

Nasal commensal viruses may worsen allergic rhinitis by activating type I IFN-linked neutrophils and NET formation. Ribavirin ...